Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Making the biotech IPO work

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Figure 1: Capital investment and end valuations for each technology class.


  1. Foster, R.N. Innovation: The Attacker's Advantage (Summit Books, New York; 1986).

    Book  Google Scholar 

  2. Christensen, C.M. & Raynor, M.E. The Innovator's Solution: Creating and Sustaining Successful Growth (Harvard Business School Press, Boston; 2003).

    Google Scholar 

  3. McNamee, L.M. & Ledley, F.D. Nat. Biotechnol. 30, 937–943 (2012).

    Article  CAS  Google Scholar 

  4. DiMasi, J.A., Feldman, L., Seckler, A. & Wilson, A. Clin. Pharmacol. Ther. 87, 272–277 (2010).

    Article  CAS  Google Scholar 

  5. Gschwind, A., Fischer, O.M. & Ullrich, A. Nat. Rev. Cancer 4, 361–370 (2004).

    Article  CAS  Google Scholar 

  6. Sheridan, C. Nat. Biotechnol. 29, 121–128 (2011).

    Article  CAS  Google Scholar 

  7. Cockburn, I.H.R. Proc. Natl. Acad. Sci. USA 93, 12725–12730 (1996).

    Article  CAS  Google Scholar 

  8. Pisano, G.P. Science Business: the Promise, the Reality, and the Future of Biotech (Harvard Business School Press, Boston; 2006).

    Google Scholar 

  9. Guedj, I. & Scharfstein, D. Organizational Scope and Investment: Evidence from the Drug Development Strategies of Biopharmaceutical Firms. NBER working paper 10933 (National Bureau of Economic Research, 2004).

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Fred Ledley.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

McNamee, L., Ledley, F. Making the biotech IPO work. Nat Biotechnol 31, 969–970 (2013).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing